Literature DB >> 26945629

Serum amyloid A1: Structure, function and gene polymorphism.

Lei Sun1, Richard D Ye2.   

Abstract

Inducible expression of serum amyloid A (SAA) is a hallmark of the acute-phase response, which is a conserved reaction of vertebrates to environmental challenges such as tissue injury, infection and surgery. Human SAA1 is encoded by one of the four SAA genes and is the best-characterized SAA protein. Initially known as a major precursor of amyloid A (AA), SAA1 has been found to play an important role in lipid metabolism and contributes to bacterial clearance, the regulation of inflammation and tumor pathogenesis. SAA1 has five polymorphic coding alleles (SAA1.1-SAA1.5) that encode distinct proteins with minor amino acid substitutions. Single nucleotide polymorphism (SNP) has been identified in both the coding and non-coding regions of human SAA1. Despite high levels of sequence homology among these variants, SAA1 polymorphisms have been reported as risk factors of cardiovascular diseases and several types of cancer. A recently solved crystal structure of SAA1.1 reveals a hexameric bundle with each of the SAA1 subunits assuming a 4-helix structure stabilized by the C-terminal tail. Analysis of the native SAA1.1 structure has led to the identification of a competing site for high-density lipoprotein (HDL) and heparin, thus providing the structural basis for a role of heparin and heparan sulfate in the conversion of SAA1 to AA. In this brief review, we compares human SAA1 with other forms of human and mouse SAAs, and discuss how structural and genetic studies of SAA1 have advanced our understanding of the physiological functions of the SAA proteins.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute-phase response; Gene polymorphism; Induced expression; Inflammation; Lipid metabolism; Serum amyloid A

Mesh:

Substances:

Year:  2016        PMID: 26945629      PMCID: PMC5683722          DOI: 10.1016/j.gene.2016.02.044

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  125 in total

1.  Acute-phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis.

Authors:  Roman Thaler; Ines Sturmlechner; Silvia Spitzer; Scott M Riester; Monika Rumpler; Jochen Zwerina; Klaus Klaushofer; Andre J van Wijnen; Franz Varga
Journal:  FASEB J       Date:  2014-12-09       Impact factor: 5.191

2.  Is the serum amyloid A we use really serum amyloid A? Comment on the article by Connolly et al.

Authors:  Ben van den Brand; Claire Waterborg; Wim van den Berg; Fons van de Loo
Journal:  Arthritis Rheum       Date:  2013-01

3.  SAA does not induce cytokine production in physiological conditions.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Nancy R Webb; Frederick C de Beer
Journal:  Cytokine       Date:  2012-11-17       Impact factor: 3.861

4.  Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice.

Authors:  Lee J Quinton; Matthew T Blahna; Matthew R Jones; Eri Allen; Joseph D Ferrari; Kristie L Hilliard; Xiaoling Zhang; Vishakha Sabharwal; Hana Algül; Shizuo Akira; Roland M Schmid; Stephen I Pelton; Avrum Spira; Joseph P Mizgerd
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

5.  A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil.

Authors:  C J Furlaneto; A Campa
Journal:  Biochem Biophys Res Commun       Date:  2000-02-16       Impact factor: 3.575

6.  Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice.

Authors:  Maria C De Beer; Joanne M Wroblewski; Victoria P Noffsinger; Debra L Rateri; Deborah A Howatt; Anju Balakrishnan; Ailing Ji; Preetha Shridas; Joel C Thompson; Deneys R van der Westhuyzen; Lisa R Tannock; Alan Daugherty; Nancy R Webb; Frederick C De Beer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-21       Impact factor: 8.311

7.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

8.  Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome.

Authors:  Claudia Paret; Zorica Schön; Adrianna Szponar; Gyula Kovacs
Journal:  Eur Urol       Date:  2009-08-27       Impact factor: 20.096

9.  The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6.

Authors:  J C Betts; J K Cheshire; S Akira; T Kishimoto; P Woo
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

10.  Is serum amyloid A an endogenous TLR4 agonist?

Authors:  Silvana Sandri; Dunia Rodriguez; Eliane Gomes; Hugo Pequeno Monteiro; Momtchilo Russo; Ana Campa
Journal:  J Leukoc Biol       Date:  2008-02-05       Impact factor: 4.962

View more
  54 in total

1.  SAA1 regulates pro-labour mediators in term labour by activating YAP pathway.

Authors:  Yanmin Jiang; Li Pin; Weiqun Shi; Qian Huang; Lele Wang; Huishu Liu
Journal:  Mol Cell Biochem       Date:  2021-03-15       Impact factor: 3.396

2.  Expression and clinical significance of serum amyloid A and interleukin-6 in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Yongtao Wei; Songxia Wang; Dongping Wang; Cheng Liu
Journal:  Exp Ther Med       Date:  2019-12-20       Impact factor: 2.447

3.  Structural Basis for Lipid Binding and Function by an Evolutionarily Conserved Protein, Serum Amyloid A.

Authors:  Nicholas M Frame; Meera Kumanan; Thomas E Wales; Asanga Bandara; Marcus Fändrich; John E Straub; John R Engen; Olga Gursky
Journal:  J Mol Biol       Date:  2020-02-06       Impact factor: 5.469

4.  Dietary α-cyclodextrin reduces atherosclerosis and modifies gut flora in apolipoprotein E-deficient mice.

Authors:  Toshihiro Sakurai; Akiko Sakurai; Ye Chen; Boris L Vaisman; Marcelo J Amar; Milton Pryor; Seth G Thacker; Xue Zhang; Xujing Wang; Yubo Zhang; Jun Zhu; Zhi-Hong Yang; Lita A Freeman; Alan T Remaley
Journal:  Mol Nutr Food Res       Date:  2017-02-24       Impact factor: 5.914

5.  Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury.

Authors:  Ni Cheng; Yurong Liang; Xiaoping Du; Richard D Ye
Journal:  EMBO Rep       Date:  2018-08-20       Impact factor: 8.807

6.  Serum amyloid A sequesters diverse phospholipids and their hydrolytic products, hampering fibril formation and proteolysis in a lipid-dependent manner.

Authors:  Shobini Jayaraman; Donald L Gantz; Christian Haupt; Marcus Fändrich; Olga Gursky
Journal:  Chem Commun (Camb)       Date:  2018-04-03       Impact factor: 6.222

7.  Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.

Authors:  Pierre-Jean Saulnier; Brad P Dieter; Stephanie K Tanamas; Sterling M McPherson; Kevin M Wheelock; William C Knowler; Helen C Looker; Rick L Meek; Robert G Nelson; Katherine R Tuttle
Journal:  Am J Nephrol       Date:  2017-09-22       Impact factor: 3.754

8.  Gastric perforation caused by secondary systemic amyloidosis.

Authors:  Hiroto Yamamoto; Akihiko Yokota; Noriyuki Suzuki; Mitsuhiro Tachibana; Yutaka Tsutsumi
Journal:  Clin Case Rep       Date:  2021-05-24

9.  Serum amyloid A1 as a biomarker for radiation dose estimation and lethality prediction in irradiated mouse.

Authors:  Jinfeng Huang; Zhenhua Qi; Min Chen; Ting Xiao; Jian Guan; Meijuan Zhou; Qi Wang; Zhongwu Lin; Zhidong Wang
Journal:  Ann Transl Med       Date:  2019-12

Review 10.  Novel insights into the pathological mechanisms of metabolic related dyslipidemia.

Authors:  Xin Su; Ye Cheng; Guoming Zhang; Bin Wang
Journal:  Mol Biol Rep       Date:  2021-07-04       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.